PEGylated-PLGA microparticles containing VEGF for long term drug delivery

International Journal of Pharmaceutics

Volumn 440, Issue 1, 2013, Pages 13-18

  Simón Yarza, Teresa ^a   Formiga, Fabio R ^a   Tamayo, Esther ^a   Pelacho, Beatriz ^b   Prosper, Felipe ^b   Blanco Prieto, María J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Macrophage uptake; PEG; PLGA; Protein delivery; VEGF

Indexed keywords

DRUG CARRIER; GROWTH FACTOR; MACROGOL 400; POLY(LACTIC CO GLYCOLIC) ACID; POLYLACTIC ACID; POLYVINYL ALCOHOL; RESOMER; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CELL ENCAPSULATION; CELL LINE; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; IN VITRO STUDY; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PARTICLE SIZE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY; PROTEIN TRANSPORT; UMBILICAL VEIN ENDOTHELIAL CELL; ZETA POTENTIAL;

ANIMALS; CELL LINE; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE; MICROSPHERES; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; POLYVINYL ALCOHOL; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84871622076     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.07.006     Document Type: Article

References (32)

1. A. Abuchowski, T. van Es, N.C. Palczuk, and F.F. Davis Alteration of immunological properties of bovine serum albumin by covalent attachment of polyethylene glycol J. Biol. Chem. 252 1977 3578 3581
2. A. Abuchowski, G.M. Kazo, C.R. Verhoest Jr., T. van Es, D. Kafkewitz, M.L. Nucci, A.T. Viau, and F.F. Davis Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene glycol-asparaginase conjugates Cancer Biochem. Biophys. 7 1984 175 186
3. M.J. Blanco-Prieto, M.A. Campanero, K. Besseghir, F. Heimgartner, and B. Gander Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres J. Control. Release 96 2004 437 448
4. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
5. S. Davis, Y.K. Park, A. Abuchowski, and F.F. Davis Hypouricaemic effect of polyethyleneglycol modified urate oxidase Lancet 2 1981 281 283
6. J. Dickinson, and S. Fowler Quantification of proteins on western blots using ECL J. Walker, The Proteins Protocols Handbook second ed. 2002 Humana Press Inc. Totowa, NJ 429 437
7. N. Doshi, and S. Mitragotri Macrophages recognize size and shape of their targets PLoS One 5 2010 e10051
8. S. Essa, J.M. Rabanel, and P. Hildgen Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles Eur. J. Pharm. Biopharm. 75 2010 96 106
9. S. Essa, J.M. Rabanel, and P. Hildgen Characterization of rhodamine loaded PEG-g-PLA nanoparticles (NPs): effect of poly(ethylene glycol) grafting density Int. J. Pharm. 411 2011 178 187
10. F.R. Formiga, B. Pelacho, E. Garbayo, G. Abizanda, J.J. Gavira, T. Simon-Yarza, M. Mazo, E. Tamayo, C. Jauquicoa, C. Ortiz-de-Solorzano, F. Prosper, and M.J. Blanco-Prieto Sustained release of VEGF through PLGA microparticles improves vasculogenesis and tissue remodeling in an acute myocardial ischemia-reperfusion model J. Control. Release 147 2010 30 37
11. F.R. Formiga, E. Tamayo, T. Simon-Yarza, B. Pelacho, F. Prosper, and M.J. Blanco-Prieto Angiogenic therapy for cardiac repair based on protein delivery systems Heart Fail. Rev. 17 2012 449 473
12. M.W. Fried, M.L. Shiffman, K.R. Reddy, C. Smith, G. Marinos, F.L. Goncales Jr., D. Haussinger, M. Diago, G. Carosi, D. Dhumeaux, A. Craxi, A. Lin, J. Hoffman, and J. Yu Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N. Engl. J. Med. 347 2002 975 982
13. E. Garbayo, E. Ansorena, J.L. Lanciego, M.S. Aymerich, and M.J. Blanco-Prieto Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres Eur. J. Pharm. Biopharm. 69 2008 844 851
14. E. Garbayo, C.N. Montero-Menei, E. Ansorena, J.L. Lanciego, M.S. Aymerich, and M.J. Blanco-Prieto Effective GDNF brain delivery using microspheres-a promising strategy for Parkinson's disease J. Control. Release 135 2009 119 126
15. R. Gref, P. Quellec, A. Sanchez, P. Calvo, E. Dellacherie, and M.J. Alonso Development and characterization of CyA-loaded poly(lactic acid)-poly(ethylene glycol)PEG micro- and nanoparticles. Comparison with conventional PLA particulate carriers Eur. J. Pharm. Biopharm. 51 2001 111 118
16. E.A. Jaffe, R.L. Nachman, C.G. Becker, and C.R. Minick Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria J. Clin. Invest. 52 1973 2745 2756
17. A. Jain, and S.K. Jain PEGylation: an approach for drug delivery. A review Crit. Rev. Ther. Drug Carrier Syst. 25 2008 403 447
18. D.P. Joshi, Y.L. Lan-Chun-Fung, and J.G. Pritchard Determination of poly(vinyl alcohol) via its complex with boric acid and iodine Anal. Chim. Acta 104 1979 153 160
19. S. Khondee, C.M. Olsen, Y. Zeng, C.R. Middaugh, and C. Berkland Noncovalent PEGylation by polyanion complexation as a means to stabilize keratinocyte growth factor-2 (KGF-2) Biomacromolecules 12 2011 3880 3894
20. K. Knop, R. Hoogenboom, D. Fischer, and U.S. Schubert Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives Angew. Chem. Int. Ed. Engl. 49 2010 6288 6308
21. S.Y. Lin, W.H. Hsu, J.M. Lo, H.C. Tsai, and G.H. Hsiue Novel geometry type of nanocarriers mitigated the phagocytosis for drug delivery J. Control. Release 154 2011 84 92
22. T. Maldiney, C. Richard, J. Seguin, N. Wattier, M. Bessodes, and D. Scherman Effect of core diameter, surface coating, and PEG chain length on the biodistribution of persistent luminescence nanoparticles in mice ACS Nano 5 2011 854 862
23. A. Maleki, A. Madadkar-Sobhani, F. Roohvand, A.R. Najafabadi, A. Shafiee, H. Khanahmad, R.A. Cohan, N. Namvar, and H. Tajerzadeh Design, modeling, and expression of erythropoietin cysteine analogs in Pichia pastoris: improvement of mean residence times and in vivo activities through cysteine-specific PEGylation Eur. J. Pharm. Biopharm. 80 2012 499 507
24. P. Milla, F. Dosio, and L. Cattel PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery Curr. Drug Metab. 13 2012 105 119
25. D.E. Owens, and N.A. Peppas Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles Int. J. Pharm. 307 2006 93 102
26. G. Pasut, M. Sergi, and F.M. Veronese Anti-cancer PEG-enzymes: 30 years old, but still a current approach Adv. Drug Deliv. Rev. 60 2008 69 78
27. H. Tanaka, R. Satake-Ishikawa, M. Ishikawa, S. Matsuki, and K. Asano Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats Cancer Res. 51 1991 3710 3714
28. K.M. Turner, G. Pasut, F.M. Veronese, A. Boyce, and G. Walsh Stabilization of a supplemental digestive enzyme by post-translational engineering using chemically-activated polyethylene glycol Biotechnol. Lett. 33 2011 617 621
29. C.J. Van Oss Phagocytosis as a surface phenomenon Annu. Rev. Microbiol. 32 1978 19 39
30. N.M. Wassef, G.R. Matyas, and C.R. Alving Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of stealth lipids Biochem. Biophys. Res. Commun. 176 1991 866 874
31. K. Yoncheva, N. Lambov, and S. Miloshev Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol Drug Dev. Ind. Pharm. 35 2009 449 454
32. Z. Zhu, C. Xie, Q. Liu, X. Zhen, X. Zheng, W. Wu, R. Li, Y. Ding, X. Jiang, and B. Liu The effect of hydrophilic chain length and iRGD on drug delivery from poly(epsilon-caprolactone)-poly(N-vinylpyrrolidone) nanoparticles Biomaterials 32 2011 9525 9535